Increased telomerase activity and comprehensive lifestyle changes: a pilot study.

BACKGROUND Telomeres are protective DNA-protein complexes at the end of linear chromosomes that promote chromosomal stability. Telomere shortness in human beings is emerging as a prognostic marker of disease risk, progression, and premature mortality in many types of cancer, including breast, prostate, colorectal, bladder, head and neck, lung, and renal cell. Telomere shortening is counteracted by the cellular enzyme telomerase. Lifestyle factors known to promote cancer and cardiovascular disease might also adversely affect telomerase function. However, previous studies have not addressed whether improvements in nutrition and lifestyle are associated with increases in telomerase activity. We aimed to assess whether 3 months of intensive lifestyle changes increased telomerase activity in peripheral blood mononuclear cells (PBMC). METHODS 30 men with biopsy-diagnosed low-risk prostate cancer were asked to make comprehensive lifestyle changes. The primary endpoint was telomerase enzymatic activity per viable cell, measured at baseline and after 3 months. 24 patients had sufficient PBMCs needed for longitudinal analysis. This study is registered on the ClinicalTrials.gov website, number NCT00739791. FINDINGS PBMC telomerase activity expressed as natural logarithms increased from 2.00 (SD 0.44) to 2.22 (SD 0.49; p=0.031). Raw values of telomerase increased from 8.05 (SD 3.50) standard arbitrary units to 10.38 (SD 6.01) standard arbitrary units. The increases in telomerase activity were significantly associated with decreases in low-density lipoprotein (LDL) cholesterol (r=-0.36, p=0.041) and decreases in psychological distress (r=-0.35, p=0.047). INTERPRETATION Comprehensive lifestyle changes significantly increase telomerase activity and consequently telomere maintenance capacity in human immune-system cells. Given this finding and the pilot nature of this study, we report these increases in telomerase activity as a significant association rather than inferring causation. Larger randomised controlled trials are warranted to confirm the findings of this study.

[1]  H. Lin,et al.  Oxidative stress induced by corticosterone administration in broiler chickens (Gallus gallus domesticus) 1. Chronic exposure. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[2]  E. Epel,et al.  Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Carroll,et al.  Relationship of Dietary Protein and Soy Isoflavones to Serum IGF-1 and IGF Binding Proteins in the Prostate Cancer Lifestyle Trial , 2007, Nutrition and cancer.

[4]  P. Carroll,et al.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention , 2008, Proceedings of the National Academy of Sciences.

[5]  Stefanie Dimmeler,et al.  Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells , 2004, Circulation research.

[6]  B. Levine,et al.  Regulated expression of telomerase activity in human T lymphocyte development and activation , 1996, The Journal of experimental medicine.

[7]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[8]  Theodore L DeWeese,et al.  Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment , 2004, Journal of cellular biochemistry.

[9]  M. Spitz,et al.  Telomere dysfunction: a potential cancer predisposition factor. , 2003, Journal of the National Cancer Institute.

[10]  J. Wilczak,et al.  Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. , 2002, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[11]  R. Moyzis,et al.  Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma , 1999, Breast Cancer Research and Treatment.

[12]  N. Mendell,et al.  Intensive lifestyle changes may affect the progression of prostate cancer. , 2005, The Journal of urology.

[13]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[14]  Lieu Tl,et al.  Obesity, cigarette smoking, and telomere length in women , 2005 .

[15]  T. Spector,et al.  Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. , 2006, The Journal of clinical endocrinology and metabolism.

[16]  Jordan W. Smoller,et al.  Telomere Shortening and Mood Disorders: Preliminary Support for a Chronic Stress Model of Accelerated Aging , 2006, Biological Psychiatry.

[17]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[18]  T. Zglinicki.  Oxidative stress shortens telomeres , 2002 .

[19]  J. Manson,et al.  Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. , 2004, The American journal of clinical nutrition.

[20]  M. Lings,et al.  Articles , 1967, Soil Science Society of America Journal.

[21]  IsabelleGorenne,et al.  Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis , 2006 .

[22]  R. Nagai,et al.  Angiotensin II and Catecholamines Increase Plasma Levels of 8-Epi-Prostaglandin F2&agr; With Different Pressor Dependencies in Rats , 2002, Hypertension.

[23]  N. Vaziri,et al.  Effect of Diet and Exercise Intervention on Blood Pressure, Insulin, Oxidative Stress, and Nitric Oxide Availability , 2002, Circulation.

[24]  A. Meikle,et al.  Combination therapy with vitamins C plus E inhibits survivin and human prostate cancer cell growth , 2004, The Prostate.

[25]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[26]  Ruth I. Tennen,et al.  Conditional telomerase induction causes proliferation of hair follicle stem cells , 2005, Nature.

[27]  N. Joste,et al.  Association between cancer-free survival and telomere DNA content in prostate tumors. , 2005, The Journal of urology.

[28]  K. Gould,et al.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.

[29]  C. Vassanelli,et al.  Enhanced Levels of Oxidized Low-Density Lipoprotein Prime Monocytes to Cytokine Overproduction via Upregulation of CD14 and Toll-Like Receptor 4 in Unstable Angina , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Axel Hoos,et al.  Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Kirkpatrick,et al.  Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress , 2006, Circulation research.

[32]  C. Young,et al.  Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4. , 2003, Urology.

[33]  K. Gould,et al.  Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.

[34]  P. Yaswen,et al.  Cancer and aging: the importance of telomeres in genome maintenance. , 2005, The international journal of biochemistry & cell biology.

[35]  Frank H. Wilhelm,et al.  Cell aging in relation to stress arousal and cardiovascular disease risk factors , 2006, Psychoneuroendocrinology.

[36]  T. Zglinicki,et al.  A continuous correlation between oxidative stress and telomere shortening in fibroblasts , 2007, Experimental Gerontology.

[37]  E. Blackburn,et al.  Telomeres and telomerase: their mechanisms of action and the effects of altering their functions , 2005, FEBS letters.

[38]  E. Frangou,et al.  Serum oxidized low‐density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients , 2006, Nephrology.

[39]  Nam W. Kim,et al.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..

[40]  R. Effros,et al.  Reduced telomerase activity in human T lymphocytes exposed to cortisol , 2008, Brain, Behavior, and Immunity.

[41]  E. Blackburn,et al.  Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Aviv,et al.  Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition , 2005, Circulation.

[43]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[44]  J. Kiecolt-Glaser,et al.  Accelerated Telomere Erosion Is Associated with a Declining Immune Function of Caregivers of Alzheimer’s Disease Patients1 , 2007, The Journal of Immunology.

[45]  G. De Backer,et al.  Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease , 2007, Aging cell.

[46]  M. Sampson,et al.  Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. , 2006, Diabetes care.

[47]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[48]  D. Grandér,et al.  Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. , 2000, Blood.

[49]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[50]  Jun-Ping Liu,et al.  TERT regulates cell survival independent of telomerase enzymatic activity , 2002, Oncogene.

[51]  V. Mohan,et al.  Telomere shortening occurs in Asian Indian Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[52]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[53]  F. Lung,et al.  Genetic pathway of major depressive disorder in shortening telomeric length , 2007, Psychiatric genetics.